The novel fluorinated carrier was used to deliver corresponding siRNA to mediate silencing of the expression of VEGF and PD-L1, effectively restoring the anti-tumor function of T cells and inhibiting tumor angiogenesis through multiple signal pathways. This evidence concerns the gene CD274 and neoplasm.